(Reuters) - U.S. drug maker Johnson & Johnson
J&J's advanced sterilization products (ASP) business, part of its Ethicon Inc unit, generated revenue of about $775 million in 2017.
Fortive, a maker of industrial products, plans to finance the acquisition through debt or equity and with available cash and said it expected the acquisition to add to adjusted earnings in the first full year after the transaction.
Everett, Washington-based Fortive was spun-off in 2016 from Danaher Corp
(Reporting by Tamara Mathias in Bengaluru; Editing by Anil D'Silva)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Updated Date: Jun 07, 2018 03:05 AM